India
· Delayed Price · Currency is INR SUNPHARMA Statistics
Total Valuation
Sun Pharmaceutical Industries has a market cap or net worth of INR 4.38 trillion. The enterprise value is 4.25 trillion.
| Market Cap | 4.38T |
| Enterprise Value | 4.25T |
Important Dates
The next estimated earnings date is Thursday, October 31, 2024.
| Earnings Date | Oct 31, 2024 |
| Ex-Dividend Date | Jul 12, 2024 |
Share Statistics
Sun Pharmaceutical Industries has 2.40 billion shares outstanding. The number of shares has decreased by -0.17% in one year.
| Shares Outstanding | 2.40B |
| Shares Change (YoY) | -0.17% |
| Shares Change (QoQ) | +0.48% |
| Owned by Insiders (%) | 11.89% |
| Owned by Institutions (%) | 27.88% |
| Float | 1.04B |
Valuation Ratios
The trailing PE ratio is 42.13 and the forward PE ratio is 39.85. Sun Pharmaceutical Industries's PEG ratio is 2.87.
| PE Ratio | 42.13 |
| Forward PE | 39.85 |
| PS Ratio | 8.89 |
| PB Ratio | 6.88 |
| P/FCF Ratio | n/a |
| PEG Ratio | 2.87 |
Enterprise Valuation
| EV / Earnings | 40.94 |
| EV / Sales | 8.64 |
| EV / EBITDA | 31.99 |
| EV / EBIT | 39.38 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 4.88 |
| Debt / EBITDA | 0.25 |
| Debt / FCF | n/a |
| Interest Coverage | 49.49 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Capital (ROIC) | 9.93% |
| Revenue Per Employee | 11.44M |
| Profits Per Employee | 2.42M |
| Employee Count | 43,000 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +59.72% in the last 52 weeks. The beta is 0.55, so Sun Pharmaceutical Industries's price volatility has been lower than the market average.
| Beta (5Y) | 0.55 |
| 52-Week Price Change | +59.72% |
| 50-Day Moving Average | 1,684.89 |
| 200-Day Moving Average | 1,504.53 |
| Relative Strength Index (RSI) | 70.90 |
| Average Volume (20 Days) | 1,898,115 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sun Pharmaceutical Industries had revenue of INR 492.09 billion and earned 103.89 billion in profits. Earnings per share was 43.31.
| Revenue | 492.09B |
| Gross Profit | 378.49B |
| Operating Income | 108.45B |
| Pretax Income | 119.88B |
| Net Income | 103.89B |
| EBITDA | 132.03B |
| EBIT | 108.45B |
| Earnings Per Share (EPS) | 43.31 |
Balance Sheet
The company has 190.90 billion in cash and 32.74 billion in debt, giving a net cash position of 158.16 billion or 65.92 per share.
| Cash & Cash Equivalents | 190.90B |
| Total Debt | 32.74B |
| Net Cash | 158.16B |
| Net Cash Per Share | 65.92 |
| Equity (Book Value) | 671.06B |
| Book Value Per Share | 265.35 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 76.92%, with operating and profit margins of 22.04% and 21.11%.
| Gross Margin | 76.92% |
| Operating Margin | 22.04% |
| Pretax Margin | 24.36% |
| Profit Margin | 21.11% |
| EBITDA Margin | 26.83% |
| EBIT Margin | 22.04% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 13.50, which amounts to a dividend yield of 0.74%.
| Dividend Per Share | 13.50 |
| Dividend Yield | 0.74% |
| Dividend Growth (YoY) | -6.90% |
| Years of Dividend Growth | 5 |
| Payout Ratio | n/a |
| Buyback Yield | 0.17% |
| Shareholder Yield | 0.91% |
| Earnings Yield | 2.37% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on July 29, 2013. It was a forward split with a ratio of 2.
| Last Split Date | Jul 29, 2013 |
| Split Type | Forward |
| Split Ratio | 2 |